Developing a vaccine against ETEC in young children has long been a global health challenge. We are now closer than ever to changing that. At Scandinavian Biopharma, we are advancing what could become the world’s first vaccine to protect young children against ETEC—a major cause of diarrhoeal disease affecting millions globally. The progress highlighted by EDCTP […]
Scientific American has highlighted ETVAX, our oral vaccine candidate targeting enterotoxigenic E. coli (ETEC) — one of the leading causes of severe diarrhoea in young children in low- and middle-income countries. The coverage follows the recent publication of our Phase 2b results in The Lancet Infectious Diseases and reflects growing recognition of the urgent need […]
Scandinavian Biopharma today announces that the comprehensive results from its Phase 2b trial of ETVAX®, the lead oral vaccine candidate against enterotoxigenic Escherichia coli (ETEC), have been published in The Lancet Infectious Diseases, one of the world’s foremost peer-reviewed medical journals. The peer-reviewed publication provides detailed analysis of the trial’s safety, immunogenicity, and efficacy outcomes […]
Our VP CMC development, Christine Hägglund, has been interviewed in the magazine Life Science Sweden. In the article, you can read about how a small company in Sweden can be so far ahead in vaccines against diarrheal diseases. Read the full article here
We are looking for a senior project manager with experience and interest in leading complex pharmaceutical manufacturing and development projects from phase III to commercialization. We have an exciting journey ahead of us and we hope you want to join us on this journey! For more information about the role as CMC Project Lead click […]
Scandinavian Biopharma is pleased to inform that Christine Hägglund has been recruited as Scandinavian Biopharmas VP CMC Development. Christine holds a PhD in Biochemistry and has almost 20 years of experience in drug development of biological pharmaceuticals. Most recently, she comes from the position of Director of Analytical Science & Technology at Sobi. “I really […]
